GNFT News and Press, GENFIT S.A.

2024-06-11 09:30:02 ET H.C. Wainwright analyst issues BUY recommendation for GNFT on June 11, 2024 07:43AM ET. The previous analyst recommendation was Buy. GNFT was trading at $5.535 at issue of the analyst recommendation. Historical Analyst Recommendations Latest ...

2024-06-07 15:00:58 ET More on the markets Going Into June, SPY Or VXF, Which Is The Better Buy? (Technical Analysis) SPY: 2 Options To Balance Out A Highly Concentrated Index Bitcoin's Fading Action Is A Huge Warning For Stock Market Liquidity Citi – ...

2024-05-29 13:52:41 ET Summary Genfit S.A. has a PDUFA date of June 10, 2024, by which time the FDA will decide upon whether elafibranor should be approved to treat patients with primary biliary cholangitis. European marketing approval of elafibranor for treatment of patients with...

2024-05-28 13:31:54 ET Summary On April 26, Gilead Sciences published financial results for the first quarter of 2024, which were better than I expected. So, total sales of oncology drugs amounted to $789 million, up about 18% yearly thanks to strong sales of Trodelvy. On May ...

Lakeland Industries Inc. (LAKE) is expected to report $0.3 for Q4 2024 Sekisui House Ltd. ADR (SKHSY) is expected to report for Q4 2024 Hingham Institution for Savings (HIFS) is expected to report for Q1 2024 GENFIT S.A. (GNFT) is expected to report for Q4 2023 Jewett-Cameron Trad...

2024-04-05 08:29:54 ET See the biggest morning stock movers . Read the full article on Seeking Alpha For further details see: Altice USA, Genfit, Brooge Energy among premarket losers' pack

2024-03-08 13:46:51 ET More on Inventiva Inventiva: Biotech To Consider Despite Short NASH Study Enrollment Pause Inventiva drops after adverse event in Phase 3 trial for NASH drug Seeking Alpha’s Quant Rating on Inventiva Historical earnings data for ...

2024-02-16 13:52:08 ET More on Inventiva Inventiva reports 9M results Seeking Alpha’s Quant Rating on Inventiva Historical earnings data for Inventiva Financial information for Inventiva Read the full article on Seeking Alpha For furthe...

2024-02-12 15:06:51 ET More on CymaBay, Gilead, etc. Gilead Sciences: Cheap For A Reason Gilead Sciences, Inc. (GILD) Q4 2023 Earnings Call Transcript Gilead Sciences, Inc. 2023 Q4 - Results - Earnings Call Presentation Gilead to acquire CymaBay for $32.50/sh...

2024-01-22 08:37:55 ET Rail Vision  ( RVSN ) +96% Successfully Secures Approval and Certifications and for EU Railway Standards. Nustar Energy ( NS ) +23% to buy NuStar in all-stock deal valued at $7.3B. MSP Recovery  ( LIFW ) +23% . North...